Withdrawal syndrome from ƒgamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats (Articolo in rivista)

Type
Label
  • Withdrawal syndrome from ƒgamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats (Articolo in rivista) (literal)
Anno
  • 2005-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1016/j.brainresprot.2005.04.001 (literal)
Alternative label
  • Carai M.A.M., Quang L.S., Atzeri S., Lobina C., Maccioni P., Orrù A., Gessa G.L., Maher T.J., Colombo G. (2005)
    Withdrawal syndrome from ƒgamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats
    in Brain research protocols
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Carai M.A.M., Quang L.S., Atzeri S., Lobina C., Maccioni P., Orrù A., Gessa G.L., Maher T.J., Colombo G. (literal)
Pagina inizio
  • 75 (literal)
Pagina fine
  • 78 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 15 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
  • 4 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 2 (literal)
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Department of Neuroscience, University of Cagliari, Cagliari, Italy; Neuropharmacology and Neurobehavioral Laboratory, Division of Pediatric Pharmacology and Critical Care, Rainbow Babies and Children's Hospital, Cleveland, OH, USA; Department of Public Health, University of Cagliari, Cagliari, Italy; C.N.R. Institute of Neuroscience, Section of Cagliari, Cagliari, Italy; Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA. (literal)
Titolo
  • Withdrawal syndrome from ƒgamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats (literal)
Abstract
  • Gamma-hydroxybutyric acid (GHB) and its precursors, 1,4-butanediol (1,4-BD) and ?-butyrolactone (GBL), are recreational drugs widely abused in the U.S., Europe, and Australasia. A severe withdrawal syndrome from GHB, 1,4-BD and GBL has been increasingly documented over the last years, necessitating the development of a reliable animal model for investigations of potential therapeutic approaches. The present study describes the induction and occurrence of audiogenic seizures as a sign of withdrawal from GHB and 1,4-BD in selectively bred Sardinian alcohol-preferring (sP) rats, treated with escalating doses of GHB (1.5-3.5 g/kg, twice daily; i.g.) or 1,4-BD (500-1000 mg/kg, twice daily; i.g.) for 9 consecutive days. Acute administration of the selective GABAB receptor antagonist, SCH 50911, dramatically increased seizure occurrence. We propose that the inherent sensitivity of sP rats to different GHB-associated responses may have contributed to the unraveling of a phenomenon which was otherwise not recognizable in other rat strains. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it